Orange Book product · Brand (NDA)
INFUGEM
GEMCITABINE HYDROCHLORIDE
At a glance
Jul 16, 2018
Approved
Brand (NDA)
Application
Not listed
TE code
1
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jul 16, 2018
8 yr 1 mo ago
Today
Patent 9241948 expires
Listed drug product patent expiration.
Jul 01, 2033
in 7 yr 2 mo
Pharmaceutical detail
Active ingredient
GEMCITABINE HYDROCHLORIDE
Strength
EQ 1200MG BASE/120ML (EQ 10MG BASE/ML)
Dosage form
SOLUTION
Route
INTRAVENOUS
TE code
Not listed
Application
NDA 208313
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2025INLEXZOBrand (NDA)
NDA 219683 · JANSSEN BIOTECH
- 2025AVGEMSIBrand (NDA)
NDA 219920 · AVYXA HOLDINGS
- 2017GEMCITABINE HYDROCHLORIDEBrand (NDA)
NDA 209604 · ACCORD HLTHCARE
- 2011GEMCITABINE HYDROCHLORIDEBrand (NDA)
NDA 200795 · HOSPIRA INC
- 1996GEMZARBrand (NDA)
NDA 020509 · LILLY
- 2023GEMCITABINE HYDROCHLORIDEGeneric (ANDA)
ANDA 213175 · HIKMA
- 2021GEMCITABINE HYDROCHLORIDEGeneric (ANDA)
ANDA 206617 · HIKMA INTL PHARMS
- 2020GEMCITABINE HYDROCHLORIDEGeneric (ANDA)
ANDA 212129 · MEITHEAL
- 2019GEMCITABINE HYDROCHLORIDEGeneric (ANDA)
ANDA 210991 · SHILPA
- 2019GEMCITABINE HYDROCHLORIDEGeneric (ANDA)
ANDA 207575 · SHILPA
- 2019GEMCITABINE HYDROCHLORIDEGeneric (ANDA)
ANDA 210383 · INGENUS PHARMS LLC
- 2018GEMCITABINE HYDROCHLORIDEGeneric (ANDA)
ANDA 209077 · SAGENT PHARMS INC
Listed patents (1)
| Patent | Expires | In | Type |
|---|---|---|---|
| 9241948 | Jul 01, 2033 | in 7 yr 2 mo | Product |

